First European Case Of Convulsions Related To Analytically Confirmed Use Of Synthetic Cannabinoid Receptor Agonist Am 2201
-
$39.95
-
1 mg
Description
This academic article presents the first documented European case of convulsions linked to the verified use of the synthetic cannabinoid receptor agonist AM-2201. Through detailed clinical reporting, researchers establish a clear connection between consumption of the substance known as Black Mamba and subsequent neurological symptoms.
